Expanding Dynamic Vergence Testing to Diverse Industries
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of dynamic vergence testing, originally designed for clinical objective testing of vergence dysfunction, to address novel applications in warehouse logistics, autonomous vehicles, athletic performance, anxiety disorders, and pilot training.
Background and Problem Solved
The original patent's dynamic vergence testing platform, including a 3D head-mounted display system with integrated eye tracking technology, was primarily focused on diagnosing and treating vergence dysfunction. However, its capabilities have broader implications for various industries where visual acuity, reaction time, and situational awareness are crucial. This inventive concept tackles the limitations of the original patent by applying its core technology to these new, high-impact areas.
Detailed Description of the Inventive Concept
The inventive concept involves adapting the dynamic vergence testing platform to optimize warehouse logistics by improving worker productivity and reducing errors. In autonomous vehicles, it enhances safety and navigation by training vehicles to respond to complex visual stimuli. For athletic performance, it improves reaction time and visual acuity. In treating anxiety disorders, it reduces symptoms and improves cognitive function. Finally, in pilot training, it enhances situational awareness and reduces errors. Each application leverages the platform's ability to simulate real-world scenarios, track eye movements, and provide personalized feedback.
Novelty and Inventive Step
The new claims introduce novel applications of the dynamic vergence testing platform, expanding its scope beyond clinical testing to diverse industries. This inventive concept's non-obviousness lies in its ability to adapt the original technology to address specific challenges in each new application area, resulting in unique solutions that improve performance, safety, and efficiency.
Alternative Embodiments and Variations
Alternative embodiments may include using augmented reality instead of 3D head-mounted displays, incorporating artificial intelligence to personalize feedback, or integrating the platform with existing training systems. Variations could also involve applying the technology to other industries, such as healthcare, education, or gaming.
Potential Commercial Applications and Market
This inventive concept has significant commercial potential in various industries, including logistics, automotive, sports, healthcare, and aviation. The market for dynamic vergence testing platforms is expected to grow as companies seek innovative solutions to improve performance, safety, and efficiency. The adaptability of this technology to diverse industries positions it for widespread adoption and significant revenue generation.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B3/113 |
| A | A61 | A61B3/0041 |
| G | G02 | G02B27/0093 |
| G | G02 | G02B27/017 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering and visual tracking technologies, specifically focused on eye movement analysis, vergence testing, and human-computer interaction systems using head-mounted display technologies
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with expertise in optometry, biomedical engineering, or human-computer interaction, possessing advanced knowledge of eye tracking technologies, 3D display systems, and adaptive testing platforms
Obviousness Rationale
A person having ordinary skill in the art would recognize the fundamental versatility of the dynamic vergence testing platform as a generalizable technology capable of adaptation across multiple domains. The core technological elements - 3D head-mounted display, integrated eye tracking, and stimulus presentation - represent a flexible framework that can be readily applied to diverse contextual challenges. The PTD demonstrates predictable extensions of the source patent's core technological principles by mapping the existing technological architecture onto different problem domains.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,258 |
|---|---|
| Title | Vergence recovery convalescence using dynamic vergence testing platform including 3D head mounted display system with integrated eye tracking technology |
| Assignee(s) | NEUROLIGN USA, LLC |